Safety Study of A-101 Topical Solution for the Treatment of Common Warts

PHASE3CompletedINTERVENTIONAL
Enrollment

426

Participants

Timeline

Start Date

February 7, 2019

Primary Completion Date

November 27, 2019

Study Completion Date

December 20, 2019

Conditions
Common Wart
Interventions
DRUG

A-101

hydrogen peroxide topical solution 45%

Trial Locations (46)

14623

Aclaris Investigational Site, Rochester

15241

Aclaris Investigational Site, Upper Saint Clair

19008

Aclaris Invesgational Site, Broomall

19034

Aclaris Investigational Site, Fort Washington

20850

Aclaris Investigational Site, Rockville

23502

Aclaris Investigational Site, Norfolk

23507

Aclaris Investigational Site, Norfolk

24501

Aclaris Investigational Site, Lynchburg

27612

Aclaris Investigational Site, Raleigh

29407

Aclaris Investigational Site, Charleston

29644

Aclaris Investigational Site, Anderson

Aclaris Investigational Site, Fountain Inn

30263

Aclaris Investigational Site, Newnan

32256

Aclaris Investigational Site, Jacksonville

33134

Aclaris Investigational Site, Miami

33144

Aclaris Investigational Site, Miami

33180

Aclaris Investigational Site, Aventura

34470

Aclaris Investigational Site, Ocala

36608

Aclaris Investigational Site, Mobile

37215

Aclaris Investigational Site, Nashville

37922

Aclaris Investigational Site, Knoxville

40241

Aclaris Investigational Site, Louisville

43209

Aclaris Investigational Site, Bexley

44122

Aclaris Investigational Site, Beachwood

46250

Aclaris Investigational Site, Indianapolis

47150

Aclaris Investigational Site, New Albany

55432

Aclaris Investigational Site, Fridley

64506

Aclaris Investigational Site, Saint Joseph

68144

Aclaris Investigational Sites, Omaha

71913

Aclaris Investigational Site, Hot Springs

72916

Aclaris Investigational Site, Fort Smith

76011

Aclaris Investigational Site, Arlington

77598

Aclaris Investigational Site, Houston

77845

Aclaris Investigational Site, College Station

78213

Aclaris Investigational Site, San Antonio

78660

Aclaris Investigational Site, Pflugerville

78759

Aclaris Investigational Site, Austin

80210

Aclaris Investigational Site, Denver

85308

Aclaris Investigational Site, Glendale

89148

Aclaris Investigational Site, Las Vegas

92024

Aclaris Investigational Site, Encinitas

92121

Aclaris Investigational Site, San Diego

92123

Aclaris Investigational Site, San Diego

92708

Aclaris Investigational Site, Fountain Valley

99202

Aclaris Investigational Site, Spokane

07044

Aclaris Investigational Site, Verona

Sponsors
All Listed Sponsors
lead

Aclaris Therapeutics, Inc.

INDUSTRY

NCT03812510 - Safety Study of A-101 Topical Solution for the Treatment of Common Warts | Biotech Hunter | Biotech Hunter